New drug targets genetic cause of kidney damage
Disease control
Recruiting now
This study is testing an investigational drug called MZE829 in adults with chronic kidney disease who have a specific high-risk genetic type (APOL1). The main goals are to see if the drug is safe and if it can reduce the amount of protein leaking into the urine, which is a sign o…
Phase: PHASE2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC